Tasoula Touloumenidou
Thessaloniki, ESYE12 57010, Greece
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
RNA Sequencing Technologies in Acute Lymphoblastic Leukemia: A Comparative Technical Review.
Journal: Current issues in molecular biology
Published: July 08, 2026
Genetic Susceptibility in Sinusoidal Obstruction Syndrome/Veno-Occlusive Disease: A Case-Control Study.
Journal: International journal of molecular sciences
Published: May 30, 2025
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR), Growth Differentiation Factor-15 (GDF-15), and Soluble C5b-9 (sC5b-9) Levels Are Significantly Associated with Endothelial Injury Indices in CAR-T Cell Recipients.
Journal: International journal of molecular sciences
Published: August 26, 2024
Increased Complement Activation and Decreased ADAMTS13 Activity Are Associated with Genetic Susceptibility in Patients with Preeclampsia/HELLP Syndrome Compared to Healthy Pregnancies: An Observational Case-Controlled Study.
Journal: Journal of personalized medicine
Published: February 12, 2024
Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) and Growth Differentiation Factor-15 (GDF-15) Levels Are Significantly Associated with Endothelial Injury Indices in Adult Allogeneic Hematopoietic Cell Transplantation Recipients.
Journal: International journal of molecular sciences
Published: November 21, 2023
Pre-Emptive Use of Rituximab in Epstein-Barr Virus Reactivation: Incidence, Predictive Factors, Monitoring, and Outcomes.
Journal: International journal of molecular sciences
Published: September 06, 2023
Genetic justification of COVID-19 patient outcomes using DERGA, a novel data ensemble refinement greedy algorithm.
Journal: Journal of cellular and molecular medicine
Published: June 12, 2023
Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter data.
Journal: Frontiers in medicine
Published: May 20, 2023
Targeted Genotyping of MIS-C Patients Reveals a Potential Alternative Pathway Mediated Complement Dysregulation during COVID-19 Infection.
Journal: Current issues in molecular biology
Published: May 19, 2022
Genetic and Functional Evidence of Complement Dysregulation in Multiple Myeloma Patients with Carfilzomib-Induced Thrombotic Microangiopathy Compared to Controls.
Journal: Journal of clinical medicine
Published: April 27, 2022
Targeted genotyping of COVID-19 patients reveals a signature of complement C3 and factor B coding SNPs associated with severe infection.
Journal: Immunobiology
Published: April 19, 2022
Last Updated: 09/26/2026